Suppressive populations like Tregs, M2-like TAMs, and MDSCs actively curtail anti-tumor immunity and promote resistance, while dysfunction or exhaustion of effector cells like CD8+ T cells and NK cells limits therapeutic efficacy. The gene discussed is CD8A; the disease is neoplasm.